EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 123 filers reported holding EPIZYME INC in Q1 2019. The put-call ratio across all filers is 1.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $376,000 | -73.4% | 36,453 | -67.7% | 0.01% | -70.0% |
| Q2 2019 | $1,415,000 | +4.6% | 112,721 | +3.2% | 0.03% | 0.0% |
| Q1 2019 | $1,353,000 | -24.1% | 109,188 | -7.5% | 0.03% | -16.7% |
| Q2 2017 | $1,783,000 | +30.5% | 118,057 | -11.5% | 0.04% | -20.0% |
| Q2 2016 | $1,366,000 | – | 133,351 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |